HCID 117697992, compound → HCID 117700251, compound
Reaction equation
[F:1][CH:2]1[CH:9]([CH2:10][C:11]([O:13]C)=[O:12])[CH2:8][CH:7]2[NH:15][CH:3]1[CH2:4][O:5][CH2:6]2.Br[CH2:17][C:18]1[NH:23][C:22]([C:24]2[S:25][CH:26]=[CH:27][N:28]=2)=[N:21][C@@H:20]([C:29]2[CH:34]=[CH:33][CH:32]=[C:31]([F:35])[C:30]=2[Cl:36])[C:19]=1[C:37]([O:39][CH3:40])=[O:38]>>[Cl:36][C:30]1[C:31]([F:35])=[CH:32][CH:33]=[CH:34][C:29]=1[C@H:20]1[C:19]([C:37]([O:39][CH3:40])=[O:38])=[C:18]([CH2:17][N:15]2[C@H:3]3[C@@H:2]([F:1])[C@H:9]([CH2:10][C:11]([OH:13])=[O:12])[CH2:8][C@@H:7]2[CH2:6][O:5][CH2:4]3)[NH:23][C:22]([C:24]2[S:25][CH:26]=[CH:27][N:28]=2)=[N:21]1Participants
3
Procedure
The title compounds were prepared in analogy to Example 86 starting from methyl 2-(6-fluoro-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)acetate 100a (100 mg) and methyl (4R)-6-(bromomethyl)-4-(2-chloro-3-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylate 88a (208 mg). The crude product was purified by silica gel chromatography first, and then by preparative HPLC to give Example 101 and Example 102.
Workup
- customThe crude product was purified by silica gel chromatography first
- customby preparative HPLC to give Example 101 and Example 102
Sources & evidence
- ORD record
- ord-7d3fe4fd4cac4160945e83e9ba70b01d
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09266904B2
Reaction notes
Loading…